IPRATROPIUM\IPRATROPIUM ANHYDROUS: 424 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
424
Total FAERS Reports
96 (22.6%)
Deaths Reported
147
Hospitalizations
424
As Primary/Secondary Suspect
87
Life-Threatening
80
Disabilities
Active Ingredient: IPRATROPIUM BROMIDE\IPRATROPIUM BROMIDE ANHYDROUS ·
First Report: 20050101 · Latest Report: 20240901
What Are the Most Common IPRATROPIUM\IPRATROPIUM ANHYDROUS Side Effects?
#1 Most Reported
Product delivery mechanism issue
105 reports (24.8%)
#2 Most Reported
Dyspnoea
77 reports (18.2%)
#3 Most Reported
Product dose omission issue
69 reports (16.3%)
All IPRATROPIUM\IPRATROPIUM ANHYDROUS Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Product delivery mechanism issue | 105 | 24.8% | 0 | 0 |
| Dyspnoea | 77 | 18.2% | 40 | 58 |
| Off label use | 69 | 16.3% | 48 | 58 |
| Product dose omission issue | 69 | 16.3% | 3 | 4 |
| Condition aggravated | 62 | 14.6% | 52 | 46 |
| Vomiting | 61 | 14.4% | 51 | 50 |
| Abdominal distension | 59 | 13.9% | 59 | 54 |
| Nausea | 56 | 13.2% | 49 | 47 |
| Drug ineffective | 54 | 12.7% | 10 | 27 |
| No adverse event | 54 | 12.7% | 0 | 0 |
| Dry mouth | 52 | 12.3% | 49 | 44 |
| Abdominal pain | 50 | 11.8% | 48 | 43 |
| Ascites | 50 | 11.8% | 50 | 45 |
| Constipation | 50 | 11.8% | 48 | 44 |
| Somnolence | 50 | 11.8% | 49 | 45 |
| Appendicitis | 48 | 11.3% | 48 | 43 |
| Appendicolith | 48 | 11.3% | 48 | 43 |
| Drug intolerance | 48 | 11.3% | 43 | 45 |
| Stress | 48 | 11.3% | 46 | 41 |
| Ventricular fibrillation | 48 | 11.3% | 48 | 43 |
Who Reports IPRATROPIUM\IPRATROPIUM ANHYDROUS Side Effects? Age & Gender Data
Gender: 13.6% female, 86.4% male. Average age: 77.6 years. Most reports from: CA. View detailed demographics →
Is IPRATROPIUM\IPRATROPIUM ANHYDROUS Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2005 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2015 | 2 | 0 | 2 |
| 2016 | 2 | 0 | 2 |
| 2017 | 1 | 0 | 0 |
| 2018 | 2 | 0 | 0 |
| 2020 | 35 | 33 | 31 |
| 2021 | 2 | 0 | 1 |
| 2022 | 28 | 0 | 1 |
| 2023 | 80 | 5 | 14 |
| 2024 | 55 | 0 | 10 |
What Is IPRATROPIUM\IPRATROPIUM ANHYDROUS Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 163 |
| Dyspnoea | 80 |
| Sleep disorder therapy | 55 |
| Intentional product misuse | 32 |
| Chronic obstructive pulmonary disease | 30 |
| Rhinorrhoea | 28 |
| Asthma | 24 |
| Off label use | 14 |
| Hypersensitivity | 13 |
| Cough | 11 |
IPRATROPIUM\IPRATROPIUM ANHYDROUS vs Alternatives: Which Is Safer?
IPRATROPIUM\IPRATROPIUM ANHYDROUS vs IPTACOPAN
IPRATROPIUM\IPRATROPIUM ANHYDROUS vs IRBESARTAN
IPRATROPIUM\IPRATROPIUM ANHYDROUS vs IRINOTECAN
IPRATROPIUM\IPRATROPIUM ANHYDROUS vs IRON
IPRATROPIUM\IPRATROPIUM ANHYDROUS vs IRON DEXTRAN
IPRATROPIUM\IPRATROPIUM ANHYDROUS vs IRON ISOMALTOSIDE 1000
IPRATROPIUM\IPRATROPIUM ANHYDROUS vs IRON POLYMALTOSE
IPRATROPIUM\IPRATROPIUM ANHYDROUS vs IRON SUCROSE
IPRATROPIUM\IPRATROPIUM ANHYDROUS vs IRON\VITAMINS
IPRATROPIUM\IPRATROPIUM ANHYDROUS vs ISATUXIMAB
Official FDA Label for IPRATROPIUM\IPRATROPIUM ANHYDROUS
Official prescribing information from the FDA-approved drug label.